SCHEMBL24933018

SCHEMBL24933018

Cc1cc(COc2ccc(Br)cc2)n(C)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.53
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
KCNH2 Q12809 1/20 0.40
MAOB P27338 3/20 0.39
MAOA P21397 2/20 0.39
APP P05067 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PKM P14618 1/20 0.38
PFKFB3 Q16875 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CRHBP P24387 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097825 0.84 FFAR1 (0.53) FFAR1KMT2AMEN1MAOBMAOA
SCHEMBL29203339 0.82 FFAR1 (0.40) FFAR1KMT2AMAOBMAOAAPP
SCHEMBL4857435 0.79 MAPT (0.40) FFAR1KMT2AKCNH2GAALMNA
SCHEMBL29203408 0.79 KDM4E (0.39) FFAR1KMT2AMAOBMAOAAPP
SCHEMBL3097893 0.79 FFAR1 (0.51) FFAR1KMT2AMAOBGAALMNA
SCHEMBL1316762 0.76 FFAR1 (0.46) FFAR1KMT2AMEN1KCNH2CYP1A2
SCHEMBL18305157 0.75 FFAR1 (0.44) FFAR1KMT2AMEN1KCNH2PFKFB3
SCHEMBL28605125 0.74 MAPT (0.41) FFAR1CYP1A2TP53GAAALDH1A1
SCHEMBL8270922 0.72 FFAR1 (0.40) FFAR1KCNH2SMN1; SMN2
SCHEMBL29203359 0.72 MAOB (0.39) KMT2AMAOBMAOAAPPCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed